Genzyme Faces Inventory Crunch As It Discards Poor Lots of Thymoglobulin
This article was originally published in The Pink Sheet Daily
Executive Summary
Manufacturing issues plague Genzyme’s Thymoglobulin as its sales grow and firm studies additional indications.